Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies
- 5 April 2006
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 15 (1) , 66-71
- https://doi.org/10.1111/j.1750-3639.2005.tb00101.x
Abstract
The central pathological cause of Alzheimer disease (AD) is hypothesized to be an excess of beta-amyloid (Abeta) which accumulates into toxic fibrillar deposits within extracellular areas of the brain. These deposits disrupt neural and synaptic function and ultimately lead to neuronal degeneration and dementia. In addition to the pathological roles attributed to Abeta, evidence from our laboratory would suggest that Abeta serves a physiological role in the modulation of CRE-directed gene expression. This commentary also highlights some of the pathological consequences of the accumulation of intracellular Abeta. Finally it discusses the impact of cortical Abeta burden on transmitter-specific synaptic numbers as well as the generation of dystrophic neurites. The fundamental thesis of my proposal is that the Abeta pathology seen in AD is a continuous process from an initial abnormal Abeta intracellular accumulation to the well-established extracellular Abeta aggregation, culminating in the formation of amyloid plaques and dystrophic neurites.Keywords
This publication has 60 references indexed in Scilit:
- Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor proteinJournal of Neuroscience Research, 2004
- Toward Alzheimer Therapies Based on Genetic KnowledgeAnnual Review of Medicine, 2004
- Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neuronsNeuroscience, 2004
- Identity and function of γ‐secretaseJournal of Neuroscience Research, 2003
- Triple-Transgenic Model of Alzheimer's Disease with Plaques and TanglesNeuron, 2003
- Long-Term Potentiation Is Increased in the CA1 Area of the Hippocampus of APPswe/ind CRND8 MiceNeurobiology of Disease, 2002
- Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic MiceBrain Pathology, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neuronsThe Journal of cell biology, 2002
- β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not CompromisedJournal of Biological Chemistry, 2001